Amgen Stock Analysis (NASDAQ:AMGN)
Amgen Analysis Video
View Amgen stock analysis video. This is our AMGN analyst opinion covering the buy and sell arguments for AMGN stock.
Amgen, Inc. Stock Rating (4.5/5)
Our Amgen stock opinion is based on fundamentals of the company. This Amgen stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.
Should you buy AMGN stock?
- The TTM operating margin was good at 43.5% for Amgen.
- Net margins came in at average 34.4% for Amgen over the last twelve months.
- AMGN stock is trading at an earnings multiple of 13 which is better than the industry average of 22.5.
- Amgen generates a high return on invested capital of 36.3%.
- Amgen has a good Return On Equity (ROE) of 26.3%.
- Amgen has a healthy FCF (Free Cash Flow) margin of 40.6%.